Hennion & Walsh Asset Management’s Larimar Therapeutics LRMR Stock Holding History

Hennion & Walsh Asset Management’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.82M	Buy	570,361 +173,635	+44%	+$671K	0.05%	406
2026 Q2	$1.21M	Buy	+396,726	New	+$1.58M	0.03%	515

Other funds holding LRMR

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Hennion & Walsh Asset Management's LRMR Position: Q3 2026 in Review

Hennion & Walsh Asset Management increased its Larimar Therapeutics (LRMR) stake by 44% in Q3 2026, buying an estimated $671K and bringing the position to 570,361 shares worth $1.82M. The position accounts for 0.05% of the portfolio, ranked #406.

Hennion & Walsh Asset Management first reported a position in LRMR in Q2 2026 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.

Hennion & Walsh Asset Management held 570,361 shares of Larimar Therapeutics worth $1.82M as of Q3 2026.
Hennion & Walsh Asset Management bought 173,635 Larimar Therapeutics shares in Q3 2026, an estimated $671K.
Larimar Therapeutics made up 0.05% of Hennion & Walsh Asset Management's portfolio in Q3 2026, its #406 holding.
Hennion & Walsh Asset Management first reported a position in Larimar Therapeutics in Q2 2026 and has held it in 2 quarters since.
7 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.